Trial
NCT05606315
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Nanfang Hospital, Southern Medical University
Collaborators
Peking University Shenzhen Hospital
Condition
Sedation
Intervention
Remimazolam Besylate
Why stopped
The trial was terminated early because additional sites did not recruit as planned, making the multicenter sample size infeasible. Enrollment ended after 117 participants were randomized at Nanfang Hospital, unrelated to safety, efficacy, or outcomes
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-02